Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 78,360 | 60,228 | 24,618 | -73,876 | -53,134 |
| Depreciation Amortization | 193,061 | 133,958 | 66,970 | 265,288 | 192,341 |
| Accounts receivable | -111,058 | -33,723 | 21,146 | -162,155 | -134,514 |
| Other Working Capital | -192,226 | -141,488 | -106,380 | -4,068 | -25,923 |
| Other Operating Activity | 241,540 | 72,252 | 1,054 | 269,910 | 198,251 |
| Operating Cash Flow | $209,677 | $91,227 | $7,408 | $295,099 | $177,021 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -54,295 | -39,245 | -13,598 | -60,340 | -37,876 |
| Purchase Sale Intangibles | -12,514 | -5,100 | -4,200 | -14,650 | -14,050 |
| Other Investing Activity | -12,514 | -5,100 | -4,200 | -2,656 | -9,061 |
| Investing Cash Flow | $-66,809 | $-44,345 | $-17,798 | $-62,996 | $-46,937 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 218,000 | 218,000 | N/A | 48,000 | 48,000 |
| Debt Issued | 2,694,750 | N/A | 218,000 | N/A | N/A |
| Debt Repayment | -2,805,384 | -251,076 | -235,528 | -188,918 | -133,383 |
| Common Stock Issued | 1,407 | 754 | 69 | 1,154 | 1,003 |
| Other Financing Activity | -130,183 | -48,531 | -21,707 | -72,027 | -66,207 |
| Financing Cash Flow | $-21,410 | $-80,853 | $-39,166 | $-211,791 | $-150,587 |
| Exchange Rate Effect | -1,471 | -777 | -470 | -999 | -259 |
| Beginning Cash Position | 118,420 | 118,420 | 118,420 | 99,107 | 99,107 |
| End Cash Position | 238,407 | 83,672 | 68,394 | 118,420 | 78,345 |
| Net Cash Flow | $119,987 | $-34,748 | $-50,026 | $19,313 | $-20,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | 209,677 | 91,227 | 7,408 | 295,099 | 177,021 |
| Capital Expenditure | -55,674 | -40,624 | -14,122 | -60,340 | -37,876 |
| Free Cash Flow | 154,003 | 50,603 | -6,714 | 234,759 | 139,145 |